Medicare & Medicaid
The complaint alleges that Regeneron fraudulently inflated Medicare reimbursement rates for a retinal disease drug.
CHCs report that Medicaid disenrollment has affected patients across all ages, including those with major health needs.
CMS is setting fixed payments and is closing loopholes that result in commissions above this amount.
Enrollees in zero-premium plans are three times as likely to be nonwhite and are more likely to live in urban areas.
Members will be able to receive care from primary care providers, behavioral health providers and community health partners.
Total gross Medicare spending on GLP-1 drugs has skyrocketed, rising from $57 million in 2018 to $5.7 billion in 2022.
The policies put pressure on benefits and premiums as insurers are already facing regulatory changes and higher utilization, AHIP says.
The proposed rates for hospices that do not submit required quality data would be -1.4%.
CMS wants to expand its ability to impose financial penalties for health and safety deficiencies.
This is despite payment errors under Medicaid dropping by $30 billion from the previous year.